This page contains exclusive content for the member of the following sections: TTS, TID. Log in to view.
Presenter: Nicholas Mueller, Arnaldo Colombo, Marwan Azar, Daniel Kaul, , ,
Authors: Nicholas Mueller, Arnaldo Colombo, Marwan Azar, Daniel Kaul, Maricar Malinis, Olivia Smibert
After graduation in 1990 (University of Zurich Medical School) Nicolas Mueller was Board certified in Internal Medicine in 1998 and in Infectious Diseases in 2004. In 2005 he was appointed senior lecturer at the University of Zurich and is a senior attending physician at the Division of Infectious Diseases and Hospital Epidemiology at the University Hospital Zurich.
His is involved in the routine care of transplanted patients. Basic research interests are viral infections in animal models of allo- and xenotransplantation, which he studied in the laboratory of Dr. Jay Fishman from 1998 to 2003. Currently, Dr. Mueller is involved in the Swiss Transplant Cohort Study on a local and national level and conducts epidemiological and translational studies in the field of transplant infectious diseases.
Arnaldo L Colombo, MD, PhD, FECMM, is a Professor of Medicine at Escola Paulista de Medicina-Federal University of Sao Paulo (UNIFESP) and Head of the Division of Infectious Diseases at the Hospital Sao Paulo-UNIFESP. Dr Colombo is President Elect of the International Society of Human and Animal Mycology-ISHAM, Senior Advisor of the Global Action Fund for Fungal Infections (GAFFI), and member of the International Council for supporting WHO in defining the Fungal Priority Pathogens List and characterize the global burden of antifungal resistance with Candida (GLASS-Candida). He coordinated and active participated of several multicenter epidemiologic studies to characterize the burden and natural history of fungal infections due to Candida, Aspergillus and Trichosporon in Brazil and Latin America. He coordinated or had active participation in several regional (LATAM and BRAZIL) and global guidelines (ISHAM-ECMM initiatives) for the clinical management of opportunistic fungal infections.
Marwan Mikheal Azar, MD, FAST, FIDSA is an Assistant Professor of Medicine (Infectious Diseases) and Laboratory Medicine at Yale University, the Fellowship Program Director for the Infectious Disease fellowship at Yale and co-director of the 2nd year Transplant infectious diseases/immunocompromised host specialty track. He is a past member of the Infectious Diseases Society of America Diagnostics committee, a current advisor to the Clinical and Laboratory Standards Institute fungal antifungal subcommittee and a current member of both the IDSA and the American Society of Transplantation Education committees. He recently chaired an AST-sponsored consensus conference to define the utility of advanced infectious disease diagnostics in solid organ transplant recipients.
Daniel Kaul MD is a professor of internal medicine in the division of infectious disease and the University of Michigan. He directs the transplant infectious disease service as well as the infectious disease training program. Dr. Kaul served as chair of the OPTN Disease Transmission Advisory Committee and currently serves on the ATC Program Committee. He has been the local principal investigator on numerous clinical trials of antiviral agents as well as investigator initiated trials.
By viewing the material on this site you understand and accept that:
Transplant Infectious Disease
740 Notre-Dame Ouest
Montréal, QC, H3C 3X6